562 related articles for article (PubMed ID: 26686425)
1. Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.
Au JL; Yeung BZ; Wientjes MG; Lu Z; Wientjes MG
Adv Drug Deliv Rev; 2016 Feb; 97():280-301. PubMed ID: 26686425
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery and transport to solid tumors.
Jang SH; Wientjes MG; Lu D; Au JL
Pharm Res; 2003 Sep; 20(9):1337-50. PubMed ID: 14567626
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
Jia M; Zhang D; Zhang C; Li C
J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
[TBL] [Abstract][Full Text] [Related]
5. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
Muntimadugu E; Kommineni N; Khan W
Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
[TBL] [Abstract][Full Text] [Related]
7. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics.
Steichen SD; Caldorera-Moore M; Peppas NA
Eur J Pharm Sci; 2013 Feb; 48(3):416-27. PubMed ID: 23262059
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle mediated cancer immunotherapy.
Gupta J; Safdari HA; Hoque M
Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
[TBL] [Abstract][Full Text] [Related]
9. Engineering extracellular matrix to improve drug delivery for cancer therapy.
He X; Yang Y; Li L; Zhang P; Guo H; Liu N; Yang X; Xu F
Drug Discov Today; 2020 Sep; 25(9):1727-1734. PubMed ID: 32629171
[TBL] [Abstract][Full Text] [Related]
10. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
11. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.
Stylianopoulos T; Munn LL; Jain RK
Trends Cancer; 2018 Apr; 4(4):292-319. PubMed ID: 29606314
[TBL] [Abstract][Full Text] [Related]
12. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment.
Kanapathipillai M; Brock A; Ingber DE
Adv Drug Deliv Rev; 2014 Dec; 79-80():107-18. PubMed ID: 24819216
[TBL] [Abstract][Full Text] [Related]
14. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.
Kirtane AR; Kalscheuer SM; Panyam J
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1731-47. PubMed ID: 24036273
[TBL] [Abstract][Full Text] [Related]
15. Barriers to drug delivery in interventional oncology.
Sheth RA; Hesketh R; Kong DS; Wicky S; Oklu R
J Vasc Interv Radiol; 2013 Aug; 24(8):1201-7. PubMed ID: 23735316
[TBL] [Abstract][Full Text] [Related]
16. Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment.
Ivey JW; Bonakdar M; Kanitkar A; Davalos RV; Verbridge SS
Cancer Lett; 2016 Sep; 380(1):330-9. PubMed ID: 26724680
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
18. Electrostatic driven transport enhances penetration of positively charged peptide surfaces through tumor extracellular matrix.
Mohanty RP; Liu X; Ghosh D
Acta Biomater; 2020 Sep; 113():240-251. PubMed ID: 32428687
[TBL] [Abstract][Full Text] [Related]
19. Tumor Microenvironment-Enabled Nanotherapy.
Wang L; Huo M; Chen Y; Shi J
Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
[TBL] [Abstract][Full Text] [Related]
20. The Tumor Microenvironment as a Barrier to Cancer Nanotherapy.
Curtis LT; Frieboes HB
Adv Exp Med Biol; 2016; 936():165-190. PubMed ID: 27739048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
